BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3884411)

  • 1. The treatment of senile dementia associated with cerebrovascular insufficiency: a comparative study of buflomedil and dihydrogenated ergot alkaloids.
    Jansen W; Bruckner GW; Jansen P
    J Int Med Res; 1985; 13(1):48-53. PubMed ID: 3884411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of buflomedil on behaviour, memory, and intellectual capacity in patients with dementia. A placebo-controlled study.
    Levinson B; Wright P; Barklem S
    S Afr Med J; 1985 Aug; 68(5):302-7. PubMed ID: 3898413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of buflomedil in geriatric patients suffering from vascular cerebral insufficiency.
    Demichelis Genesio MA; Sanz MC
    Angiology; 1981 Oct; 32(10):717-28. PubMed ID: 7034593
    [No Abstract]   [Full Text] [Related]  

  • 4. Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases.
    Clissold SP; Lynch S; Sorkin EM
    Drugs; 1987 May; 33(5):430-60. PubMed ID: 3297620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methodology of a controlled trial of dihydroergotoxine in acquired intellectual impairment in the adult].
    Dartigues JF; Père JJ
    Presse Med; 1983 Dec; 12(48):3173-5. PubMed ID: 6228936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride].
    Ciuffetti G; Mercuri M; Lombardini R; Palazzetti D; Rizzo MT; Parnetti L
    Minerva Med; 1989 Nov; 80(11):1237-40. PubMed ID: 2689916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacological effects of buflomedil in patients with multi-cerebral infarcts dementia: an open, preliminary assessment.
    Karoutas G; Milonas I; Artemis N; Karacostas D; Pitas J; Logothetis J
    Curr Med Res Opin; 1987; 10(6):380-9. PubMed ID: 3568750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of long-term safety data with buflomedil.
    Bachand RT; Dubourg AY
    J Int Med Res; 1990; 18(3):245-52. PubMed ID: 2193838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentre clinical placebo-controlled study with buflomedil in the treatment of mild dementia of vascular origin.
    Cucinotta D; Aveni Casucci MA; Pedrazzi F; Ponari O; Capodaglio M; Valdina P; Toxiri I; Bartorelli L; Granata Q; Franzini C
    J Int Med Res; 1992 Apr; 20(2):136-49. PubMed ID: 1521670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydergine: a review of 26 clinical studies.
    McDonald RJ
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Nov; 12(6):407-22. PubMed ID: 538085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticlopidine-pentoxifylline combination in the treatment of atherosclerosis and the prevention of cerebrovascular accidents.
    Apollonio A; Castignani P; Magrini L; Angeletti R
    J Int Med Res; 1989; 17(1):28-35. PubMed ID: 2651175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of chronic cerebrovascular insufficiency. Controlled comparative study of 2 cerebral antihypoxidosis agents].
    Szobor A; Klein M; Bräuer H
    MMW Munch Med Wochenschr; 1982 Oct; 124(41):897-900. PubMed ID: 6815511
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of pharmacologic treatment associated with motor-activation therapy in the prevention of senile impairment].
    Belloi L; Pirani A; Bongiorno G; Melloni M; Dinelli M; Francia R; Gallerani A; Vecchi GP
    Minerva Med; 1987 Oct; 78(20):1543-50. PubMed ID: 3670697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug therapy of disorders of cerebral performance. Randomized comparative study of dihydroergotoxine and Ginkgo biloba extract].
    Gerhardt G; Rogalla K; Jaeger J
    Fortschr Med; 1990 Jun; 108(19):384-8. PubMed ID: 2199358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buflomedil in arterial occlusive disease: results of a controlled multicenter study.
    Trübestein G; Balzer K; Bisler H; Klüken N; Muller-Wiefel H; Unkel B; Mahfoud Y; Ziegler W
    Angiology; 1984 Aug; 35(8):500-5. PubMed ID: 6383127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of buflomedil hydrochloride on the rheological properties of the blood in chronic cerebrovascular diseases].
    Lombardini R; Ciuffetti G; Paltriccia R; Scarponi AM; Savastano V; Palazzetti D; Mercuri M; Parnetti L
    Ric Clin Lab; 1989; 19 Suppl 1():117-9. PubMed ID: 2629069
    [No Abstract]   [Full Text] [Related]  

  • 17. An ergot alkaloid preparation (Hydergine) in the treatment of dementia: critical review of the clinical literature.
    Hughes JR; Williams JG; Currier RD
    J Am Geriatr Soc; 1976 Nov; 24(11):490-7. PubMed ID: 823192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral vasodilators (second of two parts).
    Cook P; James I
    N Engl J Med; 1981 Dec; 305(26):1560-4. PubMed ID: 7031468
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of buflomedil in the treatment of post-traumatic cerebral edema].
    Urciuoli R; Reggio S
    Agressologie; 1988 May; 29(6):469-71. PubMed ID: 3213896
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of chronic cerebrovascular insufficiency: comparison of nimodipine and dihydroergotoxine].
    Cosmi F; Caresia L; Panebianco G
    Clin Ter; 1986 Feb; 116(3):213-20. PubMed ID: 3698528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.